Effect of Foot Structure and Foot and Body Posture on Gait and Balance in Duchenne Muscular Dystrophy

• ClinicalTrials.gov Identifier: NCT04353167
• Recruitment Status: Recruiting
• First Posted: April 20, 2020
• Last Update Posted: July 29, 2020
• Sponsor: Hacettepe University
• Information provided by (Responsible Party): Güllü AYDIN, Hacettepe University

Study Description

Brief Summary:

Foot and body postures of patients with DMD will be evaluated. Foot structure characteristics such as foot length, metatarsal width, calcaneal valgus angle will be calculated for the foot posture. Also, the Foot Posture Index (FPI-6) scale will be used. The body posture will be evaluated with the New York Posture Scale. Many gait fcharacteristics such as step length, cadence, support surface of the patients will be determined with GaitRite instrumented walkway. Patients' balance assessment will be evaluated with Bertec Balance Advantage. The statistical analysis method will determine the relationship between foot and body posture and gait and balance.

Condition or disease	Intervention/treatment
Foot Posture; Balance; Gait Disorders, Neurologic; Body Posture	Other: observational evaluation

Study Design

• Study Type: Observational
• Estimated Enrollment: 30 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Hacettepe University
• Actual Study Start Date: June 15, 2019
• Actual Primary Completion Date: March 15, 2020
• Estimated Study Completion Date: September 10, 2020

Groups and Cohorts

Intervention Details:

• Other: observational evaluation
  Patients will be evaluated only observationally without intervention

Outcome Measures

Primary Outcome Measures :

1. GaitRite instrumented walkway [ Time Frame: 10 minutes ]
   The GAITRite® mat was positioned on the floor and connected to a laptop computer, with a 2 m acceleration/deceleration walkway at either end. Subjects were asked to walk at their typical speed to the designated end of the walkway.
2. Bertec Balance [ Time Frame: 10 minutes ]
   The system consists of a 20 × 20-inch platform at ground level connected to a laptop computer. The balance plate detects body sway based on the pressure that the subject's feet apply to the plate surface. For testing, each subject stood for 10 seconds under 4 different testing conditions. The first two conditions were eyes open and eyes closed on the balance plate itself, defined as normal stability - eyes open (NSEO) and normal stability - eyes closed (NSEC). These were followed by the patient standing on a 4-inch thick foam rubber pad while on the balance plate. These were labeled as perturbed stability - eyes open (PSEO) and perturbed stability - eyes closed (PSEC). The primary measure assessed by the balance plate for each condition was maximum center of pressure excursion or COP (a distance measured in inches of the major axis of an ellipse calculated along the axis of maximum excursion).

Secondary Outcome Measures :

1. Foot Posture Index - 6 [ Time Frame: 10 minutes ]
   The Foot Posture Index - 6 (FPI-6) was evaluated with each child standing and using the original protocol. FPI-6 values ranged from -2 to +2 for each of the six criteria and from -12 to +12 for the total score, indicative of position of each foot along the supinated to pronated continuum of foot posture.
2. NewYork Posture Scale [ Time Frame: 10 minutes ]
   The assessment of posture was done by New York Posture Rating Scale in which subjects were asked to stand in position of comfort and look forward on the wall at their eye level in order to establish a level head position. Then the plumb line was keptslightly anterior to right malleolus for assessing posture in sagittal plane and at midpoint between the feet for assessingin the frontal plane. Scoring isdone as 5, 3, 1 for no deviation, some deviation and marked deviation respectively for each 13 criteria in the rating scale of which components are head, shoulder, spine, hip, feet, arches in the frontal plane and head, chest, shoulder, upper back, trunk, abdomen and low back in the sagittal plane.

Eligibility Criteria

• Ages Eligible for Study: 5 Years to 13 Years (Child)
• Sexes Eligible for Study: Male
• Accepts Healthy Volunteers: No
• Sampling Method: Non-Probability Sample

Study Population

Study population include just patients with Duchenne Muscular Dystrophy

Criteria

Inclusion Criteria:

1. To be between 5-13 years old
2. Being at level I or II according to Brooke Lower Extremity Functional Classification Scale
3. In the balance assessment, there should be at least 90 degrees of joint range of motion in the ankle to provide base contact on the force platform.
4. Agree to participate in the research voluntarily

Exclusion Criteria:

1. Having serious mental and psychological problems,
2. Failure to cooperate adequately with the physiotherapist making the evaluations,
3. Severe contracture in lower extremities,
4. Any injury and / or surgery of the lower extremities in the past 6 months.

Contacts and Locations

Contacts

Contact: Güllü Aydın, MSc; +905536140823; gulluaydin23@gmail.com

Contact: Öznur Yılmaz, Prof.

Locations

Turkey

Hacettepe University; Recruiting

Ankara, Sıhhiye, Turkey, 06100

Contact: Öznur Tunca Yılmaz, Prof. +903123051576 ext 145 oznurtunca@yahoo.com

Contact: Güllü Aydın, R.A +903123051576 ext 179 gulluaydin23@gmail.com

Sponsors and Collaborators

Hacettepe University

More Information

• Responsible Party: Güllü AYDIN, Principal Investigator, Hacettepe University
• ClinicalTrials.gov Identifier: NCT04353167
• Other Study ID Numbers: GO19548
• First Posted: April 20, 2020
• Last Update Posted: July 29, 2020
• Last Verified: July 2020

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: Undecided

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:

Nervous System Diseases; Gait Disorders, Neurologic; Neurologic Manifestations